SCHEMBL562147

SCHEMBL562147

COc1cc(C)cc(OC)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.63
ACHE P22303 2/20 0.59
PKM P14618 2/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA3 P07451 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
LMNA P02545 1/20 0.54
GAA P10253 2/20 0.52
MAPT P10636 2/20 0.52
KMT2A Q03164 2/20 0.52
ABL1 P00519 1/20 0.48
BCR P11274 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10053939 0.90 SELL (0.62) ERN1ACHEPKMCA12CA1
SCHEMBL7520392 0.87 ERN1 (0.57) ERN1ACHEPKMCA12CA1
SCHEMBL678214 0.87 ERN1 (0.57) ERN1ACHEPKMCA12CA1
SCHEMBL29200150 0.85 ERN1 (0.50) ERN1ACHEPKMCA12CA1
SCHEMBL19225422 0.84 ALDH1A1 (0.56) ERN1ACHEPKMCA12CA1
SCHEMBL12584694 0.84 ERN1 (0.53) ERN1ACHEPKMCA12CA1
SCHEMBL14430069 0.84 ERN1 (0.53) ERN1ACHEPKMCA12CA1
SCHEMBL3292936 0.84 ALOX5 (0.67) ERN1ACHEGAAMAPTKMT2A
SCHEMBL11857409 0.84 ERN1 (0.53) ERN1ACHEPKMCA12CA1
SCHEMBL16888133 0.82 ERN1 (0.52) ERN1ACHEGAAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 840 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583708-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2025-07-16 EP claimed
US-12351761-B2 Catalytic process OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2025-07-08 US claimed
CN-120132841-A M/ZrO2-In2O3Monoatomic catalyst and preparation method and application thereof 湘潭大学 2025-06-13 CN claimed
CN-120091758-A Arthropod control composition 弗门尼舍有限公司 2025-06-03 CN claimed
CN-120028465-A Method for simultaneously detecting 3,4, 5-trimethoxytoluene TMT and 2, 6-dimethoxy-4-methylphenol DMMP in honey and application thereof 秦皇岛海关技术中心 2025-05-23 CN claimed
US-20250129315-A1 COMPOSITIONS AND METHODS FOR HYDROLYSIS OF SMOKE-ASSOCIATED GLYCOSIDICALLY-BOUND VOLATILE PHENOLS UNIV CALIFORNIA (US) 2025-04-24 US claimed
CN-119859557-A Multi-ring high-energy fuel and preparation method thereof 天津大学 2025-04-22 CN claimed
CN-119570027-B Colored end-capped photosensitive polymer, preparation method and application thereof, black photoresist and black matrix 上海明士华新材料有限公司 2025-04-18 CN claimed
US-20250122451-A1 COMPOSITIONS AND METHODS FOR HYDROLYSIS OF SMOKE-ASSOCIATED GLYCOSIDICALLY-BOUND VOLATILE PHENOLS UNIV CALIFORNIA (US) 2025-04-17 US claimed
US-20250113823-A1 Arthropod Control Compositions FIRMENICH SA (CH) 2025-04-10 US claimed
US-6376538-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASES BIOGEN, INC. 2002-04-23 US claimed
CN-1341090-A Process for preparing benzyl ethers RHODIA CHIMIE SA (FR) 2002-03-20 CN claimed
WO-2002000040-A1 A METHOD OF PREPARING LIQUID SMOKE DANFO A/S (DK) 2002-01-03 WO claimed
US-6306840-B1 ANTISTICKING AGENTS OF OLIGOPEPTIDES BIOGEN, INC. 2001-10-23 US claimed
EP-0805796-A1 CELL ADHESION INHIBITORS BIOGEN, INC. (US) 1997-11-12 EP claimed
CN-1142255-A Multicomponent system for modifying decomposing or bleaching lignin, lignin-containing materials or similar substances and method of using this system LIGNOZYM GMBH (DE) 1997-02-05 CN claimed
WO-1996022966-A1 CELL ADHESION INHIBITORS BIOGEN, INC. (US) 1996-08-01 WO claimed
CN-86100772-A 2,3-dimethoxy-5-methyl isophthalic acid, 4-benzoquinones synthetic method 1987-01-31 CN claimed
EP-0012939-B1 PROCESS FOR THE PRODUCTION OF 4-HYDROXYBENZALDEHYDE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-01-26 EP claimed
EP-0012939-A1 Process for the production of 4-hydroxybenzaldehyde derivatives SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-07-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12351761-B2 Catalytic process BBOX1, HAAO, HAO2 ERN1 1361/4885ACHE 72/4885PKM 2375/4885
US-20250113823-A1 Arthropod Control Compositions AGO2, EXOSC9, C5 ERN1 2384/4885ACHE 6/4885PKM 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.